Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong

[1]  Lennart Sjöberg,et al.  Ahlstrand E , Persson L , Tidefelt U , Söderquist B. Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis , 2011 .

[2]  E. Lau,et al.  Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant Staphylococcus aureus in intensive care unit , 2010, BMC infectious diseases.

[3]  D. Gerding,et al.  Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production , 2010, Journal of bacteriology.

[4]  P. Mastrantonio,et al.  Clostridium difficile Isolates Resistant to Fluoroquinolones in Italy: Emergence of PCR Ribotype 018 , 2010, Journal of Clinical Microbiology.

[5]  A. Tatem,et al.  Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread , 2010, The Lancet Infectious Diseases.

[6]  Stuart Johnson,et al.  Effectiveness of Alcohol-Based Hand Rubs for Removal of Clostridium difficile Spores from Hands , 2010, Infection Control & Hospital Epidemiology.

[7]  Mark A. Miller,et al.  Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  K. To,et al.  Clostridium difficile ribotype 027 arrives in Hong Kong. , 2009, International journal of antimicrobial agents.

[9]  R. Lewis,et al.  Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin Production , 2009, Journal of bacteriology.

[10]  V. Cheng,et al.  Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[11]  Nandini Dendukuri,et al.  Hand Hygiene with Soap and Water Is Superior to Alcohol Rub and Antiseptic Wipes for Removal of Clostridium difficile , 2009, Infection Control & Hospital Epidemiology.

[12]  D. Paredes-Sabja,et al.  Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD). , 2009, Microbiology.

[13]  T. Brüning,et al.  Rapid detection of the Clostridium difficile ribotype 027 tcdC gene frame shift mutation at position 117 by real-time PCR and melt curve analysis , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  M. Herrmann,et al.  Characterisation of Clostridium difficile isolates by slpA and tcdC gene sequencing. , 2009, International journal of antimicrobial agents.

[15]  J. Coia.  What is the role of antimicrobial resistance in the new epidemic of Clostridium difficile? , 2009, International journal of antimicrobial agents.

[16]  Wandi Zhang,et al.  Detection and Toxin Typing of Clostridium perfringens in Formalin-Fixed, Paraffin-Embedded Tissue Samples by PCR , 2009, Journal of Clinical Microbiology.

[17]  C. von Eichel-Streiber,et al.  Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  J. Corver,et al.  Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  S. Persson,et al.  New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  D. Paredes-Sabja,et al.  Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD). , 2008, Microbiology.

[21]  A. Widmer,et al.  Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006–2007 , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[22]  Evelyn Lo,et al.  UV-visible marker confirms that environmental persistence of Clostridium difficile spores in toilets of patients with C. difficile-associated diarrhea is associated with lack of compliance with cleaning protocol.e , 2008, BMC infectious diseases.

[23]  M. Unemo,et al.  Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1 , 2008, Journal of Clinical Microbiology.

[24]  V. Cheng,et al.  Outbreak of human metapneumovirus infection in psychiatric inpatients: implications for directly observed use of alcohol hand rub in prevention of nosocomial outbreaks. , 2007, The Journal of hospital infection.

[25]  Jane W. Marsh,et al.  Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  Carlene A. Muto,et al.  Asymptomatic Clostridium difficile colonization: is this the tip of another iceberg? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  M. Wilcox,et al.  Efficacy of Hospital Cleaning Agents and Germicides Against Epidemic Clostridium difficile Strains , 2007, Infection Control & Hospital Epidemiology.

[29]  V. Fraser,et al.  Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. , 2007, American journal of infection control.

[30]  D. Gerding,et al.  In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004 , 2007, Antimicrobial Agents and Chemotherapy.

[31]  T. Horan,et al.  Recommendations for Surveillance of Clostridium difficile–Associated Disease , 2007, Infection Control & Hospital Epidemiology.

[32]  K. Yuen,et al.  Diagnostic application of genotypic identification of mycobacteria. , 2006, Journal of medical microbiology.

[33]  T. Åkerlund,et al.  Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates , 2006, Journal of Clinical Microbiology.

[34]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[35]  L. Lanthier,et al.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Jon Brazier,et al.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.

[37]  M. Wilcox,et al.  Molecular Epidemiology of Endemic Clostridium difficile Infection and the Significance of Subtypes of the United Kingdom Epidemic Strain (PCR Ribotype 1) , 2005, Journal of Clinical Microbiology.

[38]  R. Stafford,et al.  Fluoroquinolone prescribing in the United States: 1995 to 2002. , 2005, The American journal of medicine.

[39]  Louis Valiquette,et al.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.

[40]  R. Gaynes,et al.  Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  A. Harris,et al.  difficile–associated Diarrhea , 2022 .

[42]  M. Wilcox,et al.  Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. , 2001, The Journal of hospital infection.

[43]  M. Loeb,et al.  Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea , 2001, Infection Control & Hospital Epidemiology.

[44]  F. Barbut,et al.  Epidemiology of Clostridium difficile-associated infections. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[45]  M. Wilcox,et al.  Molecular epidemiology of endemic Clostridium difficile infection , 2001, Epidemiology and Infection.

[46]  M. Wilcox,et al.  Hospital disinfectants and spore formation by Clostridium difficile , 2000, The Lancet.

[47]  M. Delmée,et al.  Comparison of PCR-Ribotyping, Arbitrarily Primed PCR, and Pulsed-Field Gel Electrophoresis for Typing Clostridium difficile , 2000, Journal of Clinical Microbiology.

[48]  C. Kelly,et al.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. , 2000, The New England journal of medicine.

[49]  J. Brazier,et al.  PCR Targeted to the 16S-23S rRNA Gene Intergenic Spacer Region ofClostridium difficile and Construction of a Library Consisting of 116 Different PCR Ribotypes , 1999, Journal of Clinical Microbiology.

[50]  M. Samore,et al.  Clostridium difficile colonization and diarrhea at a tertiary care hospital. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  M. Delmée,et al.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection , 1994, Infection and immunity.

[52]  L. Peterson,et al.  Nosocomial Clostridium difficile colonisation and disease , 1990, The Lancet.

[53]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[54]  L. Peterson,et al.  In vitro activity of efrotomycin, ciprofloxacin, and six other antimicrobials against Clostridium difficile. , 1987, Diagnostic microbiology and infectious disease.

[55]  R. Möllby,et al.  Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. , 1985, The Journal of infectious diseases.

[56]  J. Bartlett,et al.  Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. , 1981, Gastroenterology.

[57]  J. Bartlett,et al.  In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis , 1980, Antimicrobial Agents and Chemotherapy.

[58]  A. Hedges,et al.  Comparison of the precision obtained in counting viable bacteria by the spiral plate maker, the droplette and the Miles & Misra methods. , 1978, The Journal of applied bacteriology.